AbCellera Biologics Inc.
ABCL
Kedudukan dalam Saham
#4143
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Harga Saham
$11.99
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$3.88B
Perubahan (1 hari)
1.57%
Perubahan (1 tahun)
104.52%
Negara
CA
Perdagangan AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
Sejarah pecahan saham untuk AbCellera Biologics Inc. (ABCL)
Saham AbCellera Biologics Inc. (simbol: ABCL) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham ABCL yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham ABCL.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham ABCL yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham ABCL.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
